AssessmentExecutive Assessment
 
       
Executive Team
 

Iyabode Akinsanya-Beysolow,
MD, MPH


Andrew Angelino,
MD


Paul G. Auwaerter,
MD, MBA, FACP, FIDSA

John G. Bartlett,
MD

David Bell,
MD, MPH

Wendy Bennett,
MD, MPH


Deanna Bridge Najera,
MPAS, MS, PA-C, NCC, DFAAPA, CAQ-Psych


Todd T. Brown,
MD, Phd


Michael A. Chattergoon,
MD, PhD


Stephen Clement,
MD


Joseph Cofrancesco Jr.,
MD, MPH, FACP


Calvin J. Cohen,
MD, MSc


Sara E. Cosgrove,
MD, MS


Thomas Donner,
MD, (planning committee)


Sandra Adamson Fryhofer,
MD, MACP, FRCP


Joel E. Gallant,
MD, MPH


Om P. Ganda,
MD


Amita Gupta,
MD, MHS


Lawrence Herman,
MPA, RPA-C, DFAAPA


Charles Hicks,
MD


Christopher Hoffmann,
MD, MPH


Michael D. Hogue,
PharmD, FAPha, FNAP


Rita Rastogi Kalyani,
MD, MHS


Rebecca A. Kazin,
MD


Armand Krikorian,
MD, FACE


Clare J. Lee,
MD


Gregory M. Lucas,
MD, PhD


David H. Madoff,
MD, PhD


Kieren A. Marr,
MD


Nisa M. Maruthur,
MD, MHS


Nestoras Mathioudakis,
MD


Michael Melia,
MD


Dionissios Neofytos,
MD, MPH


Eric Nuermberger,
MD


Kathleen R. Page,
MD


Godfrey Pearlson,
MA, MBBS


Trish M. Perl,
MD, MSc


Paul A. Pham,
PharmD


Philip Raskin,
MD, FACP, FACE, CDE


Richard E. Rothman,
MD, PhD, FACEP


Catherine Salva,
MD


Paul E. Sax,
MD


Margot L. Savoy,
MD, MPH, FAAFP, FABC, CPE, CMQ


Jay Shubrook,
DO, FACOFP, FAAFP


Aniket R. Sidhaye,
MD


Mark S. Sulkowski,
MD


Glenn Treisman,
MD, PhD


Aimee K. Zaas,
MD, MHS


Farhad Zangeneh,
MD, FACP, FACE
 

Title: "Herpes Zoster Vaccination: What Clinicians Need to Know to Improve Vaccination Rates”

Jointly presented by: Johns Hopkins School of Medicine, American Academy of PAs, and Postgraduate Healthcare Education, LLC

Release Date: November 30, 2019
Expiration Date: November 30, 2020

Estimated time to complete this activity:
30 minutes for each of the two activities. Each part of the activity has been approved for a maximum of 0.50 AMA PRA Category 1 Credit(TM). 1.0 ANCC contact hour (0.5 contact hour of pharmacotherapy credit) is also available. There are no fees or prerequisites.

Acknowledgement of Commercial Support: Supported by an independent educational grant from GlaxoSmithKline


Executive Team

"Confronting Barriers to HPV Vaccination”

"Addressing the Challenges of HPV Vaccination”

"Multidisciplinary Care in Schizophrenia: Exploring Models, Addressing Barriers and Providing Optimal Treatment”

"Management of Persistent Hyperglycemia in T2DM: Beyond Starting Doses of Basal Insulin”

"Challenging Cases in the Diagnosis and Management of Invasive Fungal Infections”

"Basal Insulin and Beyond: Management of Persistent Hyperglycemia in T2DM”

"Optimal Immunization Strategies in Adults under 65”

"Diabetes and Pregnancy: Updated Screening and Treatment Guidelines to Improve Outcomes”

"Improving Patient Outcomes: Hypoglycemia Risk Reduction in Patients with Type 2 Diabetes Mellitus”

"Innovations in Prandial Glucose Control for Patients with Type 2 Diabetes Mellitus”

"Implementing IDSA and ADA Guidelines for the Management of Diabetic Foot Infection”

"Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections Part 2”

"Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections Part 1”

“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes Part 2: Managing Persistent Hyperglycemia”

“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes - Part 1: Lifestyle Modifications and First-Line Agents”

“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”

“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”

“Identification and Treatment of Community-Associated MRSA”

“Highlights from the 19th Conference on Retroviruses and Opportunistic Infections: CROI in Context”

“Key Clinical Updates from the 18th Conference on Retroviruses and Opportunistic Infections”

“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”

“Assessing and Managing Cardiovascular Risk in Patients with HIV”

"Guidelines and Practice in Initiating Antiretroviral Therapy in 2011"